HomeAUPH • NASDAQ
add
Aurinia Pharmaceuticals Inc
Previous close
$5.17
Day range
$5.09 - $5.55
Year range
$4.71 - $12.43
Market cap
729.40M USD
Avg Volume
1.40M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 45.10M | 58.59% |
Operating expense | 61.62M | 11.16% |
Net income | -26.88M | -3.18% |
Net profit margin | -59.60 | 34.93% |
Earnings per share | -0.19 | -5.56% |
EBITDA | -18.82M | 32.48% |
Effective tax rate | -1.74% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 350.37M | -10.00% |
Total assets | 548.06M | 16.40% |
Total liabilities | 170.11M | 160.00% |
Total equity | 377.95M | — |
Shares outstanding | 144.62M | — |
Price to book | 1.97 | — |
Return on assets | -10.78% | — |
Return on capital | -12.37% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -26.88M | -3.18% |
Cash from operations | 14.31M | 36.96% |
Cash from investing | -6.26M | -107.32% |
Cash from financing | -5.58M | -910.61% |
Net change in cash | 2.48M | -69.48% |
Free cash flow | 17.97M | -26.02% |
About
Founded
2012
Headquarters
Website
Employees
300